{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-314422","form_type":"8-K","ticker":"KYMR","cik":"0001815442","company_name":"Kymera Therapeutics, Inc.","filed_at":"2025-12-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.561777+00:00","generated_at":"2026-05-16T13:39:47.519007+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Kymera prices upsized $602M public offering; net ~$656M for pipeline","bullets":["Priced 7,000,000 shares at $86.00 per share; gross proceeds $602M.","Underwriters exercised option to purchase additional 1,050,000 shares in full.","Net proceeds estimated at ~$656.1M after discounts and expenses.","Cash runway extended into 2029; funds to advance degrader pipeline and working capital.","Offering expected to close December 11, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-314422","json":"https://secwatch.observer/filing/0001193125-25-314422.json","markdown":"https://secwatch.observer/filing/0001193125-25-314422.md","text":"https://secwatch.observer/filing/0001193125-25-314422.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815442/000119312525314422/0001193125-25-314422-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815442/000119312525314422/d89982d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:39:47.519007+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}